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Biocontainment is an integral part of biomedical research that aims to protect the environment 
and human health by containing hazardous or invasive organisms in the laboratory. 
Containment systems often rely on elaborate genetic circuits; however, cells may escape 
containment by developing mutations that render the genetic circuits inviable or resistant to 
killing mechanisms. The aim of this thesis was to create a site-specific nuclease for 
biocontainment of plasmids in the mammalian gastrointestinal tract.  LAGLIDADG homing 
endonucleases would be good candidate nucleases for a biocontainment system as they are 
resistant to mutations in their coding sequence and their target sequence in comparison to other 
nucleases, such as Cas9. Screening mutagenic libraries of the I-OnuI nuclease yielded a single 
variant that displays thermosensitive properties in vivo that may prove useful for 
biocontainment purposes. Using thermosensitive LAGLIDADG homing endonucleases for 
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Summary for Lay Audience 
Biocontainment is an essential part of biomedical research that aims to protect the environment 
and human health by containing potentially hazardous organisms in the laboratory. Efforts to 
develop containment systems often rely on elaborate and expansive DNA circuits. The 
methods used previously also raise the concern that the cells may be able to escape 
containment, either through mutations that break the DNA circuits or by the evolution of 
resistance to killing mechanisms. Nucleases, which are enzymes that cut DNA, are attractive 
candidates for use as a containment mechanism. DNA cutting proteins that can target internal 
DNA sequences are called endonucleases (in comparison to exonucleases which target the 
ends). LAGLIDADG homing endonucleases are small, yet highly specific DNA cutting 
proteins that are resistant to mutations in their DNA sequence and the particular sequence they 
cut (in comparison to other DNA cutting proteins). As a result of their resilience and 
specificity, homing endonucleases from the LAGLIDADG family were chosen as the 
candidate enzymes for developing a biocontainment mechanism. Screening libraries of 
LAGLIDADG DNA cutting enzymes yielded a single type that displays temperature-sensitive 
properties when used in a bacterial cell. Temperature sensitivity is useful as a biocontainment 
mechanism as it means the bacterial cell can only survive in a specific temperature range. These 
properties may prove helpful for biocontainment purposes in that it could be used as a new, 
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Chapter 1  
1 Introduction 
1.1 Objective Statement  
The goal of this thesis is to develop and test thermosensitive site-specific LAGLIDADG 
homing endonucleases that target specific sequences in synthetic plasmids and 
chromosomes for use as genetic kill switches. The existing systems are of limited utility 
across all potential applications that require genetically programmed means of 
biocontainment, and this will be expanded upon below. Employing LAGLIDADG homing 
endonucleases as the containment method will allow for a more robust and modular 
application of this biocontainment strategy as they are relatively small (approximately 1 kb 
in size or less), yet reliable in comparison to other nucleases. The use of temperature as a 
mediating factor controlling activity will circumvent the pitfalls associated with molecule-
based signals and allow the application of this method to be expanded to elements in which 
their very application requires mobility, such as conjugative plasmids.  
1.2 Biocontainment 
1.2.1 Historical Perspective 
Before 1951, there were no formal inquiries into the threat that biological laboratories may 
pose to their workers' health, let alone the surrounding communities or environment. The 
first survey of biological laboratories was done in the USA as a result of multiple case 
studies and reports around the world of lab workers acquiring infections from the materials 
to which they were exposed1. Thus, an attempt was made to gauge the risk involved with 
such work1. The first effort to formulate a protocol for dealing with biological agents was 
at a conference held in 1955 at Camp Detrick in Fredrick, Maryland2. At this conference, 
multiple health and safety directors, as well as scientists from military laboratories, met to 
share their knowledge of working with biological warfare agents to handle common safety 
problems collaboratively2. 
Although not formally founded until 1984, this would later become recognized as the first 
meeting of the American Biological Safety Association2. The American Biological Safety 
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Association promotes biosafety as an essential principle to reduce the likelihood of 
occupational illness using safety principles to minimize human exposure and the harmful 
impacts of research on the environment by the containment of biological agents to 
laboratories2. Employing the insight gained from the early American Biological Safety 
Association conferences, the director of health and safety at Camp Detrick, Arnold 
Wedum, published the first comprehensive biosafety guidelines in 19643.  
The beginning of the discussion concerning the biocontainment of modified organisms is 
marked by the 1975 Asilomar Conference, which was held due to concerns about how the 
recent advent of genetic engineering may affect the biosphere and human health if host 
species with non-native DNA were to escape into the environment4. This conference 
outlined four levels of risk, which track largely with the biosafety or containment levels 
used in laboratories today4. However, these four levels of containment would not become 
set in place for another 9 years by the American Biological Safety Association with the 
publication of the first edition of the "Biological Safety in Microbiology and Biomedical 
Laboratories" text4,5. At the Asilomar Conference, changes to laboratory procedures, such 
as adopting mechanical pipettes over mouth pipettes, were recommended4. Scientists 
attending the conference also theorized about adopting genetic means of containing 








Figure 1. A timeline illustrating the key historical events pertaining to 
biocontainment. Each box illustrated on the timeline is equal to a year, and double slashes 




1.2.2 An Overview of the General Methods of Genetically 
Programmed Biocontainment 
Modern systems for genetic containment are often elaborate and involve integrations or 
alterations to the host organism's genome6–8. Different strategies are combined to reduce 
the probability of host organism or vector escape6–8. An ideal design depends on the ability 
to control the system within the given context of use, prevent growth if the organism or 
vector were to escape that context, and allow for uninhibited growth within the intended 
context of application. In general, individual biocontainment strategies cluster into three 
distinct categories, as follows: addiction (which can be further broken down into 
auxotrophs and orthogonally designed systems), suicide systems, and kill switches. The 
efficacy of biocontainment systems is measured as escape frequency or colony-forming 
units that survived in non-permissive conditions per 10x (i.e., if 1 in 1000 escaped, this 
would be given as 1 in 103 or 1x10-3).  
1.2.2.1 Addiction 
Addiction based containment strategies attempt to contain the organism by generating 
strains that are unable to grow in the absence of a nutrient necessary for the replication of 
DNA or the production of proteins.  
1.2.2.1.1 Auxotrophy 
Auxotrophy, or the inability for the cell to manufacture critical nutrients, is the oldest 
method of biocontainment and is still employed today. In 1977, ΔdapD, Δasd, and ΔthyA 
Escherichia coli strain χ 1776 was developed9. This strain is incapable of growing in media 
deficient in diaminopimelic acid, lysine, threonine, methionine, thymine, or thymidine9.  
Some studies have presented their Lactococcus lactis ΔthyA auxotroph's escape rate as 
below a detectable limit10,11. However, one major problem with using auxotrophic strains 
for biocontainment is that the nutrients exist everywhere in the biosphere outside of the 
nutrient-deficient media, and the strain is therefore readily able to escape containment 
when presented with a medium as simple as sterile soil6. The problem of nutrient 
availability is especially true for thymine and thymidine auxotrophs6. Additionally, 
auxotrophic strains display growth deficiencies compared to their prototrophic 
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counterparts (strains capable of manufacturing all critical nutrients from other organic 
molecules), even in supplemented media9,12. On a positive note, this does make auxotrophs 
unlikely to take over the ecological niche of their wild-type counterparts since even 
prototrophic lab strains of E. coli do not seem to possess the capability to outcompete wild-
type strains. Overall, auxotrophic strains have limited value outside of avoiding the need 
for antibiotic-based selection in the lab13.  
1.2.2.1.2 Orthogonal Design 
Some auxotrophic strains and vectors have been created that require the supplementation 
of factors that are orthogonal to conventional biology to avoid the ecological prevalence of 
nutrients that can supplement traditional auxotrophs. The first example of an orthogonally 
designed addiction system comes from Rovner et al. (2013) where they reassigned all the 
TAG stop codons to TAA stop codons, introduced a new tRNA:aminoacyl-tRNA 
synthetase pair for the introduction p-acetyl phenylalanine at TAG (UAG) sites, and then 
added TAG codons to multiple essential genes in Methanocaldoccus jannaschii to create a 
strain that is dependent on a non-canonical amino acid14. Other examples of orthogonally 
designed strains include ones that make use of unnatural bases, expanded genetic codes, 
and ligand-dependent essential gene modifications15–18. These approaches often exhibit 
exceptionally low escape frequencies (generally around 10-11 to 10-12) and lack the growth 
deficiencies inherent to ordinary auxotrophs14,16.  
The first weakness of this approach is the possibly prohibitive cost of reagents used, 
although it is worth noting that this is not the case with the ligand-dependent essential gene 
modification approach18. Second, the reagents used in the orthogonal design process (and 
their resultant products) are potentially toxic to the environment, animals, or humans, 
thereby constricting the use of this approach to laboratories19. Third, this approach still 
involves the cumbersome creation of elaborate strains capable of using factors orthogonal 
to natural biology14,18. Finally, this approach does not allow for horizontal gene transfer, 
so it would not be a usable containment mechanism in any application dependent on 
horizontal gene transfer, such as the use of conjugative plasmids in a medical context for 
microbiome modulation20. Admittedly, the inability of orthogonal systems to undergo 
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horizontal gene transfers could potentially be an advantage of the system in some 
contexts20. 
1.2.2.2 Suicide Systems 
Another method of genetically encoded biocontainment involves the use of single genes 
that can result in cell death12,21,22. These may be used in a toxin-antitoxin context in an 
attempt to prevent horizontal gene transfer, or in combination with a repressor-based 
addiction strategy. This strategy was first proposed in 1987, involving hok under the control 
of the trp promoter12,21. In the absence of tryptophan, Hok is expressed, causing membrane 
depolarization and cell death12,21.  
The negative aspect of this style of biocontainment strategy, notwithstanding any 
drawbacks to the addiction-like strategies employed to control gene expression (e.g. pLac), 
is that suicide genes are prone to deactivating mutations and therefore are generally 
ineffective12,21. As such, the suicide system strategy's rate of escape is generally in the     10-
3  to 10-5 range7,12,23. Moreover, this strategy does not prevent the release of DNA to the 
environment when used in combination with an addiction strategy. The viability of the cell 
itself is targeted, not the DNA. This is problematic as DNA can persist in media such as 
soil, and the potential danger of release generally does not come from laboratory strains 
themselves, but the non-native or extrachromosomal DNA they may be carrying13,24. 
Finally, when used in an antitoxin-toxin sense to prevent horizontal gene transfer, even if 
an effective mechanism is devised, this containment method would not be viable for the 
containment of conjugative plasmid applications20,25.  
1.2.2.3 Kill-Switches 
Kill-switch biocontainment mechanisms target the integrity of the genetic information 
carried, as opposed to the cell's integrity through other meansI. Kill-switches can be broken 
 
I
 In the literature the terms suicide systems and kill-switches are used interchangeably. This may be due to the use of the 
term as it pertains to physical kill-switches (or emergency stops) in industry. However, given the parallels between 
synthetic biology and computer science, moving forward it should be used in a sense that aligns with the use of the term 
in software development, a program which prevents unwanted use and dissemination by rendering pirated software 
unusable. In this sense, the suicide system would be an emergency stop as it pertains to hardware (the cell), and the kill-
switch would refer to a mechanism of preventing the unwanted spread of software (DNA). 
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down into three categories: non-specific nucleases, restriction enzymes, and highly 
targeted nucleases with long recognition sequences7,26,27. Like suicide systems, this method 
can be used to contain an organism or to prevent the escape of extrachromosomal elements, 
albeit, using this method has a significant advantage in the later context if combined with 
more specific nucleases to create a self-targeting system. The first published use of this 
containment strategy consisted of the non-specific nuclease nuc under the control of 
lambda pL promoter in E. coli TGE900, which carried a thermosensitive lambda cI857 
repressor26. At 42°C, the lambda repressor becomes unstable, and Nuc is expressed, which 
results in the destruction of any genetic information, including chromosomal DNA, causing 
cell death26. This strategy has since been improved upon by using genetic circuits to control 
expression that do not rely on high temperatures and use more specific nucleases, such as 
EcoRI or CRISPR7,27. Depending on the method chosen, the reported escape frequencies 
range from  10-5 (Nuc and EcoRI) down to below a detectable limit ("Deadman" and 
"Passcode")7,26,27.  
Again, such a system's downsides will mirror those of the addiction-like molecule 
dependent systems that are relied upon to control gene expression. As such, if a naturally 
occurring molecule is used to control expression, this will result in aberrant activity in non-
permissive conditions selecting for mutations over time, which will inevitably lead to 
increased escape frequencies7. This approach's attractiveness is that if highly targeted 
nucleases with long target sites are used, the genomic DNA could be left intact while 
allowing the biocontainment system to target extrachromosomal elements exclusively. 
1.2.2.3.1 Thermosensitivity: Leaving Addiction Behind 
To overcome the drawbacks of activity controlled by an addiction strategy and retain the 
desirable feature of highly-targeted cleavage, one could potentially use a thermosensitive 
version of Cas9 to create a self-targeting kill-switch28. Thermosensitive Cas9 could prove 
an ideal strategy to prevent the escape of non-chromosomal genetic material (even 
conjugative plasmids) in the context of industrial, laboratory and medical applications of 
microbes.  
Unfortunately, guide RNA expression levels have been shown to drop drastically when the 
temperature decreases to 30°C29.  This raises the concern that a further drop to room 
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temperature may allow for a construct to escape containment. Additionally, the cas9 
sequence is relatively large (approximately 4 kb in length), reducing its attractiveness as a 
candidate nuclease to use as a plasmid-based kill-switch.  A type II restriction enzyme 
would be smaller, and one example, AbaSI, exists with no activity at 37°C and performs 
optimally at 25°C30. Unfortunately, its target sequence is relatively frequent 
(CNNNNNNNNNNNNNNNNNNNNG), and its activity is methylation-dependent30. 
Likewise, a temperature-sensitive variant of BamHI exists, but it is only active in the 30-
60°C range (which is inside of the biologically relevant range) and also suffers from a short 
target sequence (GGATCC)31.  Other thermosensitive type II restriction enzymes could be 
developed for such a purpose. However, this strategy would be quite prone to escape by 
single base-pair mutations in the target, as type II restriction enzymes are not tolerant to 
deviations in their target sequence32. The development of an ideal thermosensitive nuclease 
kill-switch system necessitates looking beyond nucleases currently employed as kill-
switches.  
1.3 LAGLIDADG Homing Endonucleases 
LAGLIDADG homing endonucleases (LHEs) are a family of selfish genetic elements 
found as free-standing genes or encoded in introns as group I introns and inteins33,34. LHEs 
are primarily found in Archaea or the organellular genomes of fungal and algal species35. 
They function as either homodimers or two-domain monomers, and their name is derived 
from the conserved residues found between the core alpha helices33,34,36,37. The side chains 
of these residues interact with the opposing alpha-helix to form the domain interface33,34,36.  
They make an attractive candidate for the development of thermosensitivity-based kill-
switches due to their inherent properties. Their long 22 bp recognition sequences make 
them precise despite retaining activity in the face of some variation in the target 
sequence33,35,38–41. This family of homing endonucleases is also resistant to point mutations 
within their coding sequence42. Additionally, these proteins display strong binding 
affinities33. LAGLIDADG homing endonuclease gene variants exist that are approximately 
1 kb in length or less, such as I-OnuI, I-LtrI, and I-HjeMI43,44. These variants are derived 
from the ascomycetes Ophiostoma novo-ulmi, Leptographium truncatum, and Hypocrea 
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jecorinaII, respectively43,44. A selfish genetic element of fungal origin would be under a 
stabilizing selection to ensure activity around the organism's growth temperature. Given 
that all three of these LAGLIDADG homing endonucleases originate from Ascomyota 
involved in plant rot-diseases, they are likely active at temperatures of 30°C or lower43,45.  
While these variants are ideal candidates for use as kill-switches, they are active at 37°C 
(the preferred temperature of E. coli and other species in human gastrointestinal 
microbiomes), as well38,44,46. Therefore, some development is required before they can be 
feasibly used as thermosensitive kill-switches in a laboratory or medical setting.  
1.3.1 Example Application 
An instance where a thermosensitive kill-switch would be an essential component for 
containment is the conjugative cas9 plasmid developed by Hamilton et al. (2019)25. The 
system Hamilton et al. (2019) are developing is a promising prospective approach to 
dealing with bacterial gastrointestinal infections because it spreads exponentially between 
bacteria in liquid culture and can efficiently target the chromosomes of Salmonella 
enterica via Cas9 nuclease variants leading to cell death25. Due to the programmability of 
the guide RNAs directing the Cas9 protein's sequence-specific targeting, a conjugative 
cas9 system will also work well for targeting other species20,47.  
 
However, the same aspects that make this system an attractive prospect for use as an 
antibiotic (exponential transfer and efficient bactericidal activity) cause concern from a 
biocontainment perspective. Escape of a conjugative plasmid carrying a cas9 construct 
from a patient's body could have wide-ranging effects from the target bacterial species 
being removed from other people's microbiome, at least, to a population bottleneck in the 
target bacterial species, at worst. Whether the large scale spread of a conjugative plasmid 
with cas9 targeting an infectious bacterial species is desirable or not is best debated 
 
II It would be more correct to refer to the source organism as Trichoderma reesei, as H. jecorina is an anamorph of T. 
reesei68. Note, this means I-HjeMI should be renamed to I-TreI to follow homing endonuclease naming conventions69. 
However, for the purpose of this thesis, I-HjeMI will be referred to as such, to avoid confusion when referring to the 
pertaining literature.  
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elsewhereIII. However, it does showcase a great example of where a thermosensitive 
nuclease-based kill-switch would be necessary to prevent escape from a narrow 
application-specific perspective. Containing Hamilton et al.'s (2019) system to the human 
gut (37°C) would alleviate the ecological and ethical concerns that an application of such 
a system on an individual would raise, thus bringing their system closer to an application 
in the medical market where novel approaches to treating bacterial infections are in 
strong demand25,48–50. 
 
III Such a debate will likely be akin to the on-going discussions concerning the potential applications of gene drives to 
eradicate or control infectious disease spreading insect and rodent species70. 
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Chapter 2  
2 Materials and Methods 
2.1 Media 
2.1.1 2xYT Media 
To make 2xYT media, 16 g of carbohydrate-free tryptone, 10 g of yeast extract, and 5 g of 
NaCl were added to 400 mL of ddH2O in a 1 L graduated cylinder and stirred until 
dissolved. The volume was adjusted to 1 L with dd H2O, and 15 g of agar A were added 
for solid media. The media was autoclaved at 120°C for 20 minutes.  
2.1.2 Modified M9 Media 
2.1.2.1 10x M9 Salt Solution 
To make 10x M9 salt solution media, 70 g of Na2HPO4•7H2O, 30 g of KH2PO4, 10 g of 
NH4Cl, and 5 g of NaCl were added to 400 mL of ddH2O in a 1 L graduated cylinder and 
stirred until dissolved. The volume was adjusted to 1 L with dd H2O.  The media was 
autoclaved at 120°C for 20 minutes. 
2.1.2.2 Selective M9 Solid Media  
To make selective M9 solid media, 8 g of carbohydrate-free tryptone was added to 280 mL 
of ddH2O in a 1 L graduate cylinder and stirred until dissolved. Then, 100 mL of 10x M9 
salt solution and 20 mL of 50% glycerol were added to the graduated cylinder.  The volume 
was adjusted to 0.996 L with ddH2O, and 15 g of agar A were added. A magnetic stir bar 
was added to the media before autoclaving. The media was then autoclaved at 120°C for 
20 minutes.  
After autoclaving, 1.0 mL of sterile 1.0M CaCl2, 1.0 mL of sterile 1.0M MgSO4, 1.0 mL of 
100 mg/mL carbenicillin suspended in 50% EtOH, 1.0 mL of sterile 20% arabinose, 400 
µL of sterile 1.0% Thiamine, and 400 µL of sterile 1.0M IPTG were slowly dripped in 
media cooled to 65°C and immediately poured into plates.  
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2.1.2.3 Non-selective M9 Solid Media 
To make non-selective M9 solid media, 8 g of carbohydrate-free tryptone was added to  
280 mL of ddH2O in a 1 L graduate cylinder and stirred until dissolved. Then, 100 mL of 
10x M9 salt solution and 20 mL of 50% glycerol were added to the graduated cylinder.  
The volume was adjusted to 0.996 L with ddH2O, and 15 g of agar A were added. A 
magnetic stir bar was added to the media and was autoclaved at 120°C for 20 minutes.  
After autoclaving, 1.0 mL of sterile 1.0M CaCl2, 1.0 mL of sterile 1.0M MgSO4, 1.0 mL of 
100 mg/mL carbenicillin suspended in 50% EtOH, 1.0 mL of sterile 20% glucose, and 400 
µL of sterile 1.0% thiamine were slowly dripped in media cooled to 65°C and immediately 
poured into plates.  
2.2 Gibson Assembly 
2.2.1 5x Reaction Buffer 
To make 5x reaction buffer, 0.2 g of PEG 8000, 0.5 mL of 1M Tris (pH 7.5), and 25 µL of 
2 M MgCl2 were rotated in a 1.5 mL Eppendorf tube for 2 hours to dissolve. Then 50 µL 
of 1 M DTT, 100 µL of dNTP mix (100 mM dGTP, 100 mM dATP, 100 mM dTTP, 100 
mM dCTP), and 100 µL of 50 mM NAD were added. The volume was adjusted to 1 mL 
with ddH2O. The 5x reaction buffer was stored at -20°C.  
2.2.2 1.33x Reaction Mixture 
To make 1.33x reaction mixture, 26.7 µL of 5x reaction buffer, 0.4 µL of T5 exonuclease 
(1.48 mg/mL), 4.8 µL Taq ligase (0.28 mg/mL), 0.7 µL of Pfu polymerase (2.5 U/µL), and 
67.3 µL of ddH2O were added to a 0.5 mL Eppendorf tube and mixed by pipetting  The 
1.33x reaction mixture was stored at -20°C. 
2.2.3 Gibson Assembly Protocol 
To begin the Gibson assembly, 2 µL of insert and 3 µL of vector were placed into a 0.2 mL 
PCR tube. The insert and vector must have approximately 40 base pairs of homology at 
their ends. Then, 15 µL of chilled 1.33x reaction mixture was added to the 0.2 mL PCR 
tube and mixed via pipetting. The 0.2 mL PCR tube was immediately transferred to a 
13 
 
thermocycler set to 50°C and incubated for 1 hour. Finally, 10 µL of the Gibson assembly 
reaction was transformed into 200 µL of CaCl2 competent E. coli cells. 
2.3 Libraries 
2.3.1 LAGLIDADG Point Mutation Libraries  
Mutagenized libraries of the LAGLIDAG homing endonucleases I-OnuI, I-LtrI and I-
HjeMI, were created using the GeneMorph II EZClone Domain Mutagenesis Kitgene51. 
Directions were followed to obtain a high mutation frequency (9-16 mutations/kb). 
Mutagenized products were digested using NcoI and NotI, and ligated into NcoI/NotI 
digested pEndo using  3:1, 5:1, and 7:1 vector to insert ratios following the NEB: Protocol 
with T4 DNA Ligase (NEB catalogue #M0202)52. These were transformed into NEB5α 
cells, and 100 µL of the recovery mixtures were plated. Theoretical complexity was 
calculated by subtracting the number of colonies on no insert control plate from that on the 
ratio plates, and then multiplying that number by the amount of 100 µL aliquots remaining 
in the recovery mixture, and added to the sum of each library generated for that variant.  
2.3.2 I-LtrI FLL_E Library 
This I-LtrI library is randomized at positions 27, 58, and 66 and consists of 8000 possible 
combinations, and was identified as a coding network46. The library was ordered as a gene 
block from IDT and cloned into pEndo by Dr. McMurrough (unpublished data). F27 is in 
the N-terminal helix, I58 is in the second helix, and W66 is located at the edge of the N-
terminal beta-sheet. All three positions are facing a hydrophobic pocket of the domain's 
core and are predicted to be involved in intra-domain stability, making this library a 
potential source of thermosensitive mutants. The FLL_E library has a complexity of 8,000 
variants 














Figure 2. Structure of I-LtrI (silver, PDB 3R7P) to DNA (yellow) in the presence of 
divalent cation cofactors (red spheres). A) Plain view of I-LtrI's structure. B) I-LtrI's 
structure rotated 90° clockwise and zoomed in for emphasis to show the residues that were 
randomized in the H1-IR library. The following residues have their side chains displayed 
and are highlighted for contrast: S20 is coloured pink, W22 is coloured light blue, T23 is 





This I-LtrI library is randomized to all 20 amino acids at positions 20, 22, 23 and 64, and 
was likewise ordered as a gene block from IDT and cloned into pEndo by Dr. McMurrough 
(unpublished data).  Positions 20, 22, and 23 are located within the N-terminal alpha-helix 
of the protein and are near the interface between the two domains of I-LtrI. Position 64 is 
located in the second alpha-helix and is a conserved residue according to an alignment done 
by Baxter et al. (2012)39. These positions should play a role in inter-domain stability and 
intra-domain stability, similarly making this library a potential source of thermosensitive 
mutants. This library contains 160,000 variants. 
2.3.4 H1-IR-RND and FLL_E-RND Combination Library  
The point mutation library of I-LtrI library was combined by co-culturing with the I-LtrI 
H1-IR and FLL_E libraries to create a combined library that was passaged through the dual 














.  Figure 3. Maps of the plasmids used in the two-plasmid screen. A) pEndo (5.0 kb) 
construct containing required components for arabinose inducible LAGLIDADG homing 
endonuclease expression. This plasmid also contains the AmpR selectable marker for 
ampicillin resistance. B) pCcdB (4.5 kb) construct with the necessary components to act 
as an IPTG inducible CcdB based negative selection for the two-plasmid screen. This 
plasmid contains the KanR selectable marker for kanamycin resistance, as well as the 
LAGLIDADG homing endonuclease cut sites. Finally this plasmid also contains a CEN-
ARS-His element from propagation in yeast. Diagrams are not to scale 
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2.4 Two-plasmid Screen 
Thermosensitive variants are identified using an E.coli two-plasmid selection system 
where one plasmid (pEndo) expresses the LHE libraries (Fig1A). The pCcdB plasmid 
contains ccdB that binds to DNA gyrase to inhibit DNA replication53. This selection is, 
therefore, bacteriostatic. pCcdB also includes the sequence of the recognition sites for the 
endonuclease expressed from pEndo. Cells survive the selection if the endonuclease 
cleaves its target on pCcdB, linearizing the plasmid and promoting its degradation. This 
two-plasmid screen is an adaption of the version previously used by McMurrough et al. 





Figure 4. Workflow of the two-plasmid screen used to identify thermosensitive LHE 
variants. M9 selective plates contain 100 µg/ml carbenicillin, 0.2% arabinose, and 0.4 
mM IPTG. M9 non-selective plates contain 100 µg/ml carbenicillin, and 0.2% glucose. 
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2.4.1 Initial Dual Plasmid Screen 
50 μL of calcium chloride competent Nova XGF' E. coli cells harbouring pCcdB with 
appropriate target sites were transformed with 50 ng of the library by a standard 45 second 
42°C heat shock protocol. The mixture was recovered for 1 hour at 37°C in 1 mL of 2xYT, 
and 100 µL of the mixture was plated on 2xYT plates containing 100 µg/ml ampicillin and 
50 µg/ml kanamycin and incubated overnight at 37°C. The wild-type positive control was 
plated on a 2xYT plate containing only 100 µg/ml ampicillin to obtain colonies (the 
positive control won't grow on double selection). E. coli transformants were screened by 
picking colonies from the 2xYT plate onto two selective M9 minimal media plates 
followed by incubation of one plate at 37°C and the second plate at 25°C. A fresh pipette 
tip was used to pick each colony. Putative thermosensitive endonuclease variants will 
promote E. coli growth at 25°C, but not at 37°C.  
2.4.2 Confirmatory Dual Plasmid Screen 
Putative clones were picked, grown overnight at 37°C in 2xYT media with ampicillin (100 
µg/ml), as well as 0.2% glucose, and were re-screened to confirm temperature dependence. 
Plasmid DNA was isolated, and 50 ng was transformed into 50 µL of calcium chloride 
competent Nova XGF' pCcdB E. coli cells. Following a 1-hour recovery at 37°C, the 
culture volume was split in half. In one culture the endonuclease on pEndo was induced 
using 0.2% arabinose while under ampicillin selection (100 µg/ml) at 25°C for 2.5 hours, 
and 37°C for 1.5 hours, respectively. The other culture contained 0.2% glucose to repress 
expression. After induction, 100 µL of each mixture was plated on selective M9 plates, and 
a non-selective plate. The two plates corresponding to the 37°C culture incubated at 37°C 





2.4.3 Survival Rate Calculation 
The survival rate was calculated for each temperature taking the ratio of the number of 
colony-forming units on the selective plate by the number of colony-forming units on the 
non-selective plate, multiplied by a hundred to obtain a percentage of survival for that 
temperature. 
2.5 Repair of the pCcdB Origin 
The pUC origin of replication from pMSP3535 (Addgene catalogue #46886) was amplified 
using primers that gave the insert 40 bp of overlap to that of pCcdB to create an origin that 
was reported to be capable of maintaining the same copy number at 25°C and 37°C55. The 
ColE1 origin of pCcdB was removed using an AattII (NEB catalogue #R0117S) and SacII 
(NEB catalogue #R0157S) double digest in NEB Cutsmart buffer for 1 hour at 37°C. These 
two fragments were then used for Gibson Assembly, as demonstrated in section 2.2. 
2.6 Protein Purification  
I-OnuI wild-type and I-OnuI G177A were previously cloned into pPROEX HTa 
(Invitrogen and Life Technologies) via its unique NcoI and NotI sites by Dr. 
McMurrough38. I-OnuI P14Q was cloned into pPROEX HTa using the same method. The 
three 6x-histidine-tagged I-OnuI variants were transformed individually into ER2566 cells 
(New England Biolabs). A 25 mL starter culture of each were grown overnight at 37°C to 
saturation in LB containing ampicillin (100 µg/ml) and 0.2% glucose. These starter cultures 
were then used to each inoculate 975 mLs of LB containing ampicillin (100 µg/ml) and 
grown to an OD600 of 0.6 at 37°C. Once an OD600 of 0.6 was reached, 1 mL of 1M IPTG 
(final concentration 1mM IPTG) was added to each of the cultures, followed by 16 hours 
of incubation at 16°C.  The cells were then harvested via centrifugation at 6,000xg, 4°C 
for 15 minutes. The resultant pellets were resuspended (40 mL/g) in binding buffer (50 
mM Tris⋅HCl, pH 8.0, 500 mM NaCl, 1 mM imidazole, and 10% glycerol), as well as 
supplemented with EDTA-free Protease Inhibitor Cocktail (Roche, 1 tablet per 50mL) and 
PMSF Protease Inhibitor (Thermo Scientific, final concentration: 0.4 mM.) The 
resuspended cell pellets were then lysed using an EmulsiFlex-C3 high-pressure 
homogenizer. The lysed cell solutions were then ultra-centrifuged at 29,000xg, 4°C for 30 
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minutes. The supernatants were loaded onto Ni2+-NTA resin. The resin was washed with 
wash buffer (50 mM Tris⋅HCl, pH 8.0, 500 mM NaCl, 35 mM imidazole, and 10% 
glycerol), and the bound protein was eluted in 6x1 mL fractions using elution buffer (50 
mM Tris⋅HCl, pH 8.0, 500 mM NaCl, 500 mM imidazole, and 10% glycerol.) The 6 
fractions for each I-OnuI variant were pooled, dialyzed in dialysis buffer (50 mM Tris⋅HCl, 
pH 8.0, 250 mM NaCl, 30 mM imidazole, and 10% glycerol), and the N-terminal 
6xhistidine tags were concomitantly cleaved using TEV protease (1:25 TEV to I-OnuI 
molar ratio.) This was done first for 1 hour at 25°C, followed by 16 hours at 4°C. The 
cleaved I-OnuI products in dialysis solution were then dialyzed into binding buffer (50 mM 
Tris⋅HCl, pH 8.0, 500 mM NaCl, 1 mM imidazole, and 10% glycerol) for 4 hours at 4°C. 
The resultant cleaved I-OnuI products with TEV were then loaded onto Ni2+-NTA resin, 
and their flow-through's were collected and dialyzed into storage buffer (50 mM Tris⋅HCl, 
pH 8.0, 25 mM NaCl, 1 mM DTT, and 10% glycerol) for 16 hours at 4°C. Following 
dialysis into storage buffer, size-exclusion chromatography using an AKTA Superdex 200 
Increase 10/300 GL column (GE product ID 28-9909-44) was performed at a flow rate of 
0.2 mL/minute, and 1 mL fractions were collected. These final fractions were then stored 
at -80°C.  
2.6.1 Second Purification of I-OnuI P14Q 
I-OnuI P14Q was purified a second time as above with some minor changes. The wash 
solution used contained 50 mM Tris⋅HCl, pH 8.0, 2 M NaCl, 35 mM imidazole, and 10% 
glycerol. Also, 6 x 2 mL fractions were collected. Finally, size exclusion was not performed 
following Ni2+-NTA immobilized metal affinity chromatography (IMAC). 
2.7 In Vitro Cleavage Assay 
I-OnuI WT, G177A, and P14Q variants were diluted to 4 µM (10x) working concentrations 
using storage buffer. A 4x reaction mixture (200 mM Tris⋅HCL (pH 8.0), 400 mM NaCl, 
40 mM MgCl2, 4 mM DTT) was mixed with the appropriate volume of pCcdB and sterile 
double deionized H2O to bring the reaction mixture to 1.11x and the concentration of 
pCcdB to 11.1 nM. Aliquots of the reaction mixture with pCcdB and the 10x protein 
samples were then incubated separately at 25°C and 37°C for 5 minutes. This assay was 
performed in parallel at 25°C and 37°C at final concentrations of 10 nM of pCcdB, and 
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400 nM of either I-OnuI WT (fraction 20), I-OnuI G177A (fraction 48), and I-OnuI P14Q 
(fraction 72) for the first 3 replicates. The 4th replicate was performed the same way except 
that the final fraction from the second purification of I-OnuI P14Q was used. The final 
composition of the reaction mixture was 50 mM Tris⋅HCL (pH 8.0), 100 mM NaCl, 10 
mM MgCl2, 1 mM DTT. The assay was stopped at 5 time points using a 2x stop solution 
(200 mM EDTA, 30% glycerol, 0.2% SDS, and bromophenol blue) and incubated at 50°C 
for 5 minutes.  
Reactions performed at 25°C were stopped at 0 minutes, 15 minutes, 30 minutes, 60 
minutes, and 120 minutes. Reactions performed at 37°C were stopped at 0 minutes, 5 
minutes, 15 minutes, 30 minutes, and 60 minutes. The percent coiled, open circle, and 
linear products were measured based on the corresponding band intensity of a 1% agarose 
as determined using the BioRad Image Lab Software v6.0.1.  
2.8 Golden Mutagenesis  
The three I-OnuI mutants (GGA2, CCG14CAG), (GGA2GGC, CAG14), and (GGC2, 
CAG14CCG) were created sequentially from WT I-OnuI (GGA2, CCG14) via golden 
mutagenesis. This was done using PCR to insert the mutation and a type IIS restriction 
enzyme site into the region where the desired mutation is to be created in a circular vector. 
(The primers used can be found in Appendix A.) Following PCR, 300 ng of the resultant 
linear DNA piece is added to a solution containing 2 µL of T4 DNA ligase buffer (NEB 
catalogue #M0202), 1 µL of T4 DNA ligase (NEB catalogue #M0202), 2 µL of 1 µg/µL 
BSA, 1 µL of BsmBI (NEB catalogue #R0580) in a fresh PCR tube on ice. This mixture is 
then filled to a total volume of 15 µL using sddH2O and mixed via gentle pipetting. The 
PCR tube containing all the above components was transferred to a thermocycler. The 
thermocycler protocol used was 37°C for 2 minutes, followed by 20°C for 5 minutes. These 
two steps were repeated 40 times and finished with a heat deactivation at 80°C for 20 
minutes. Finally, 2.2 µL of the golden mutagenesis reaction was transformed into 50 µL of 
CaCl2 competent cells via a standard heat shock transformation protocol. This is a modified 
protocol of the one described by Püllmann et al56. 
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2.9 Data Analysis  
All graphs and charts presented were generated in R studio. Means and sample standard 
deviations (represented by the error bars) shown on the in vitro cleavage charts were 
calculated in Excel. R studio's base functions were used for performing one-way ANOVA 
and Tukey post hoc tests, and the data used for these tests was the raw data (not the mean 
or standard deviations calculated in Excel). In all cases, the α value chosen was 0.05.  
2.10  Protein Structure Models 
The protein structure models presented in this study were generated using PyMol to 



















3.1 Development of a Two-Plasmid Screen that Works at                                       
__25°C and 37°C  
3.1.1 Identification of a Problem with pCcdB 
To identify thermosensitive LAGLIDADG homing endonucleases, a two-plasmid based 
survival assay based on the bacteriostatic properties of CcdB was selected based on 
previous applications to LAGLIDADG homing endonucleases38,46. To test the 
functionality of this assay at 25°C and 37°C pEndo I-Ltr and pCcdB in control experiments 
anticipating that I-LtrI WT should function at both 25°C and 37°C. As shown in Figure 5, 
I-Ltr WT survived at both temperatures. However, the negative controls (I-LtrI G185Aand 
the empty vector) could survive on selective media at 25°C but not at 37°C (Fig. 5). This 
meant that thermosensitive variants could not be distinguished from background growth. 
Sequencing of the CcdB regions of pCcdB revealed a G→A transition at position 229, 
resulting in a glycine to glutamate substitution mutation. Isolation of a clone of pCcdB 
without the G229A mutation did not resolve the issue of I-LtrI G185A and the empty vector 












 Figure 5. Two-plasmid selection using pCcdB (G299A) illustrates a problem with 
the screen at 25°C. Two-plasmid selection was performed using Nova XGF’ E. coli cells 
carrying pEndo I-LtrI WT, G185A, or an empty pEndo backbone at 37°C (red triangles) 





 Figure 6. Two-plasmid selection using pCcdB (G229A) continues to display a 
problem with the screen at 25°C. Two-plasmid selection was performed using pCcdB 
Nova XGF’ E. coli cells carrying pEndo I-LtrI WT, G185A, or an empty pEndo 
backbone at 37°C (red triangles) and 25°C (blue inverted triangles). Each point in a 
column represents an independent experiment. 
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3.1.2 Insertion in the RNAII region of the ColE1 promoter within 
pCcdB  
Following the isolation of a version of pCcdB without point mutation in the ccdB gene, 
sequencing revealed a 24 base pair insertion into the RNAII region of the ColE1 origin of 
pCcdB. Removing the origin containing the 24 base pair insertion and replacing it with a 
pUC origin resolved the problem of the negative control having a non-zero survival rate at 
25°C. Replacing the origin resulted in approximately 100% survival of the wild-type and 
approximately 0% survival of the slow (I-LtrI G185A) enzymes at both temperatures (Fig. 
7). The replacement origin was intended to be a pBR322ΔROM origin, which has been 
noted to be stable by Kobayashi et al., the key -444 base pair was a thymidine, not cytosine, 
resulting in a pUC origin55. The unintended base-pair difference resulted from an error in 
the reported sequence for pMSP3535 used to create the replacement origin of replication 















  Figure 7. Two-plasmid selection using pCcdB with a pUC origin sequence devoid of 
an insertion.  Two-plasmid selection was performed using pCcdB Nova XGF’ E. coli 
cells carrying pEndo I-LtrI WT or G185A at 37°C (red triangles) and 25°C (blue inverted 
triangles). Each point in a column represents an independent experiment. 
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3.2 Creating and Screening LHE Mutagenic Libraries 
3.2.1 LHE Mutagenic Library Complexity and Features  
Libraries were created using mutagenic PCR to introduce random mutations in the I-OnuI, 
I-LtrI, and I-HjeMI coding sequences. The resultant libraries had theoretical complexities 
in the range of approximately 21,000-53,000 variants (Table 1). Four clones sequenced 
from each library displayed relatively balanced rates of transitions to transversions, except 
for the I-OnuI clones that have approximately twice as many transitions (Table 2). Most 
mutations result in non-synonymous mutations and low rates of non-sense mutations 
(Table 2). The I-LtrI library was combined with the I-LtrI FLL_E library and I-LtrI H1-IR 












Table 1. Library theoretical complexity based on CFUs after transformation of 
ligation mixtures.  Library complexity was calculated as described in section 2.3.1. 
Group Complexity  
l-OnuI randomized  21,088 
I-LtrI randomized 52,759 



















Table 2. Sanger sequencing of 4 clones from each library.  





l-OnuI randomized 0.55:1 23.5% 76.5% 0% 
I-LtrI randomized 1.09:1 12% 84% 4% 














3.2.2 Identification of a Thermosensitive I-OnuI Variant  
A total of 2,600 colonies were passaged through the initial screen; however, this only 
resulted in 2 potential hits from the I-OnuI library to later be passaged through the 
confirmatory screen (Table 3). These resulted in one low quality hit, and one high quality 
hit that warranted sub-cloning and further investigation (Table 4). Despite considerable 
effort, the I-LtrI and I-HjeMI libraries did not yield any potential hits. To screen for 
thermosensitive variants, I-OnuI, I-LtrI, and I-HjeMI libraries were independently 
transformed into E. coli harbouring pCcdB (fixed origin) and colonies were screened at 
25°C and 37°C (Table 3). This initial screen of 608 independent I-OnuI library 
transformants resulted in 12 potential hits. Screening of 1308 and 684 independent colonies 
from the I-LtrI and I-HjeMI libraries resulted in no potential hits.  
 
The 12 preliminary I-OnuI hits were screened again by isolating pEndo from each clone 
and transforming into naive E. coli pCcdB (fixed origin). This secondary screen revealed 
that 2 of 12 clones showed thermosensitive growth (Table 4). Sequencing of these clones 
revealed one with a P14Q substitution and the other with S42Y, F116S, and K150T 
substitutions (Table 4). The I-OnuI P14Q displayed better temperature dependence, with 



















Table 2. Colonies screened in the initial and confirmatory screens.  
Group Colonies Screened Potential Hits Confirmed hits 
I-OnuI randomized 608 12 2 
I-LtrI combined library 1308 0 0 













Table 3. Survival rates of two I-OnuI hits in a confirmatory screen. This table is 
displaying data from 3 independent replicates. Note: Higher than 100% survival rates result 
from fewer colonies surviving on the non-selective M9 plates. This effect is likely partially 
due to leaky CcdB expression or the extra metabolic stress of carrying two plasmids. Also, 
the LHE would be repressed on these plates, and therefore less able to remove them 
compared to the selective condition.  
Group 
Survival % 
25°C   37°C 
Wild-type I-OnuI 108.7 82.3 
I-OnuI P14Q 101.8 0 
I-OnuI S42Y, F116S, K150T 29.2 0 








3.2.2.1 I-OnuI P14Q Appears to be a Thermosensitive Ideal 
Candidate In Vivo Based on the Two-Plasmid Screen.  
I-OnuI P14Q proved to be an exciting prospect, displaying ideal properties (Fig. 8). This 
I-OnuI variant displays 0% survival at 37°C and approximately 100% survival at 25°C. I-
OnuI P14Q behaved the same as the wild-type I-OnuI enzyme at 25°C (p=0.325, Fig. 8B), 
and the same as G177A slow mutant or empty vector at 37°C (p=0.999, Fig 8A). As a 








  Figure 8. Two-plasmid selection using pCcdB with the corrected origin sequence 
identifies I-OnuI P14Q as a hit. Two-plasmid selection was performed using pEndo 
Nova XGF’ E. coli cells carrying pEndo I-OnuI WT (N=8),  P14Q (N=8), G177A (N=3), 
and the empty vector (N=5) at 37°C (panel A, red triangles). and 25°C (panel B, blue 
inverted triangles.) Significant differences (p<0.05, Tukey’s post hoc test) between I-OnuI 




3.3 Purification of I-OnuI WT, I-OnuI G177A, and I-OnuI 
P14Q. 
The I-OnuI P14Q mutation is located at the top of the first α-helix that forms the enzyme's 
structured core (Fig 9). Therefore, it was anticipated that the P14Q mutation would result 
in temperature-sensitive activity in vitro due to misfolding. The P14Q variant was sub-
cloned from pEndo into a bacterial expression vector to test this supposition. The protein 
was purified using metal affinity and size-exclusion chromatography. The I-OnuI WT and 












Figure 9. Structure of I-OnuI (green, PDB 3QQY) to DNA (yellow) in the presence 
of a divalent cation cofactor (red sphere). Residue P14's side chain is displayed and 





3.3.1 Nickel-nitrilotriacetic Acid Immobilized Metal Affinity 
Chromatography based Purification of I-OnuI WT, I-OnuI 
G177A, and I-OnuI P14Q.  
Following the identification of a putative thermosensitive I-OnuI variant, in vitro cleavage 
assays were performed. The coding sequence of the P14Q variant of I-OnuI was moved 
into a vector with a 6x his tag and purified. The 6x his tagged P14Q variant of I-OnuI was 
expected to be 38 kDa, and TEV was expected to be 27 kDa. The final product for each 
variant (35 kDa) was not considered pure enough for downstream work, and therefore 







 Figure 10. Nickel-nitrilotriacetic acid immobilized metal affinity chromatography-
based protein purification of (A) I-OnuI wild-type, (B) I-OnuI G177A, and (C) I-
OnuI P14Q. I-OnuI wild-type, I-OnuI G177A, and I-OnuI P14Q proteins were purified 
as per methods section 2.6 Protein Purification. Protein species were resolved on SDS-
PAGE and visualized with Coomassie blue. A BLUelf pre-stained protein ladder was 
used (FroggaBio catalogue #PM808-0500G). The expected molecular weights of 6xhis + 
I-OnuI, I-OnuI, TEV, and 6xhis are 38 kDa, 35 kDa, 27 kDa and 3 kDa respectively. 
Abbreviations: TSE- total sample extract, IMAC- immobilized metal affinity 
chromatography, TEV- tobacco etch virus. 
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3.3.1.1 Size-Exclusion Chromatography based Purification of I-OnuI 
WT, I-OnuI G177A, and I-OnuI P14Q. 
Size-exclusion fractions from wild-type I-OnuI protein purification elucidated which 
subsequent fractions of I-OnuI G177A and I-OnuI P14Q would be worth retaining (Fig. 
11A). The fractions with the least contaminants based on banding patterns were retained 
for subsequent work (Fig. 11B). Fractions 18 and 19 were pooled, as were fractions 20 and 






























Figure 11. SDS-PAGE visualization of size exclusion chromatography (SEC) 
fractionation of (A) I-OnuI wild-type identified 18 mL retention volume of I-OnuI, 
which was (B) sampled in subsequent SEC of I-OnuI wild-type, I-OnuI G177A, and 
I-OnuI P14Q. After affinity chromatography, SEC was used to further separate larger 
molecular weight species. Fractions were collected as per methods section 2.6 Protein 
Purification. Protein samples were injected sequentially after allowing 0.5 column 
volumes of buffer to ensure the previous sample had eluted completely. Fraction numbers 
are indicated by the letter F at the top of the gels. For clarity, I-OnuI WT fractions 
correspond in panels (A) and (B). Protein species were resolved on SDS-PAGE, 
visualized with Coomassie blue staining, and a BLUelf pre-stained protein ladder was 




3.3.2 Second Nickel-nitrilotriacetic Acid Immobilized Metal Affinity 
Chromatography based Purification of I-OnuI P14Q 
I-OnuI P14Q was purified a second time to have another independent sample of this mutant 
protein. Using a high salt wash during this purification appears to have helped get the 
protein pure enough that size-exclusion chromatography was not required (Fig.10, Fig. 12). 
There was also less precipitation noticed during dialysis of this purification of I-OnuI 






















Figure 12. Second nickel-nitrilotriacetic acid IMAC based purification of I-OnuI 
P14Q. I-OnuI P14Q was purified as described in methods and was monitored by removing 
samples at the indicated points in the process. Protein species were resolved on SDS-
PAGE, visualized with Coomassie blue staining, and a PiNK PLUS pre-stained protein 
ladder was used (GeneDireX catalogue #PM005-0500). Abbreviations: TSE- total sample 




3.4 In Vitro Cleavage Assays Revealed No Temperature 
Dependence of I-OnuI P14Q Activity 
After protein purification, wild-type I-OnuI and I-OnuI P14Q were assayed against their 
target, pCcdB, in vitro at 25°C and 37°C (Fig. 13). The cleavage reaction appears to 
proceed through a nicked intermediate before arriving at a linear product. The nicked 
intermediate is especially apparent for I-OnuI P14Q at time points under 30 minutes at 
25°C and 37°C, causing a lower percentage of linear products (Fig. 13B, Appendix E). In 
contrast to what would be expected based on the in vivo data, there was no statistical 
difference in the rate of cleavage between wild-type I-OnuI and I-OnuI P14Q at 37°C in 
vitro (p<0.05, Fig. 19A). Purified wild-type I-OnuI and I-OnuI P14Q display rates that are 
statistically different from the purified slow mutant (I-OnuI G177A)  at both temperatures 
but not significantly different from each other at 25°C or 37°C (p<0.05, Fig. 14). This 
suggests that the protein product of I-OnuI P14Q is not responsible for the thermosensitive 









Figure 13. In vitro cleavage assay workflow (panel A) and sample gel (panel B). A) a 
cartoon representation of the in vitro cleavage assay workflow where pCcdB and an I-OnuI 
variant are mixed in a reaction solution and then stopped at various time points as described 
in the methods section. B) Sample in vitro cleavage assay agarose gels of I-OnuI WT and 
P14Q at 25°C and 37°C. These are 1% agarose gels, run at 60V until resolved, then stained 
in RedSafe Nucleic Acid Staining Solution (FroggaBio catalogue #21141), and destained 




Figure 14. In vitro cleavage assay using purified I-OnuI variants targeting pCcdB 
showed few differences between I-OnuI and P14Q at both temperatures. In vitro 
cleavage assays were performed as described in methods using purified I-OnuI WT (N=4, 
black circles),  P14Q (N=4, blue circles), and G177A (N=4, orange circles) at 37°C (panel 
A). and 25°C (panel B). Means are represented by the points on the graph, and error bars 
correspond to +/- 1 standard deviation. Significant differences (p<0.05, Tukey’s post hoc 
test) between I-OnuI variant’s generated linear DNA percent are indicated by (*, **, ***). 
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3.5 A Silent Nucleotide Substitution in Codon 2 of I-OnuI 
Determines Temperature Sensitivity 
To further understand how I-OnuI P14Q displayed temperature sensitivity in the two-
plasmid assay but not in vitro, the nucleotide sequence of P14Q was examined. In addition 
to the C→A transition that changes codon 14 from proline to glutamine (CCG→CAG), an 
additional A→C transition was found in the third position of the second codon 
(GGA→GGC) that specifies glycine. This nucleotide substitution does not change the 
codon identity. All three possible mutations of these two codons were constructed to test 
the impact on I-OnuI P14Q temperature sensitivity (Table 5). 
The in vitro cleavage assay results indicated that the protein sequence is likely not what 
was causing the thermosensitive property of I-OnuI P14Q in vivo. All 3 permutations were 
explored in an in vivo survival assay to investigate whether it was one of the mutations 
themselves or their combination that was responsible for the thermosensitive property 
(Fig.15). The only variant that was significantly different from the wild-type at 37°C was 
the one identified initially using the two-plasmid assay that contained both mutations 
(p=0.000, GGA2GGC, CCG14CAG, Fig. 15A). This result shows that both point 






Figure 15. Two-plasmid selection showing that both mutations in I-OnuI P14Q 
(GGA2GGC, CCG14CAG) are required for its thermosensitive properties. The two-
plasmid selection was performed using pEndo Nova XGF’ E. coli cells carrying pEndo I-
OnuI WT (N=3),  I-OnuI P14Q minus the silent mutation (CCG14CAG, N=3), the I-
OnuI P14Q variant originally identified (GGA2GGC, CCG14CAG, N=3), I-OnuI with 
only the silent mutation in codon 2 (GGA2GGC, N=3), and I-OnuI G177A (N=3) at 
37°C (panel A, red triangles) and 25°C (panel B, blue inverted triangles). Significant 
differences (p<0.05, Tukey’s post hoc test) between I-OnuI variant’s percent survival are 









Table 5. Changes in I-OnuI at codons 2 and 14 influence thermosensitivity in a 
survival assay. This table is displaying data from 3 independent replicates. Note: the first 
row corresponds to the wild-type enzyme. 
  
Codon 2 
 Mean Survival %  
Codon 14 25°C   37°C 
GGA CCG 98.8 98.8 
GGA CAG 99.1 99.7 
GGC CAG 95.8 1.2 




4 Discussion and Future Directions  
4.1 Development of a Two-Plasmid Screen that Works at 
25°C and 37°C  
Elucidating why the two-plasmid screen behaved in a porous manner at 25°C proved 
difficult (Fig. 5, Fig. 6). Given that a G100E mutation in ccdB is a known inactivating 
mutation, it was a logical explanation57. When removing the mutation did not resolve the 
issue, the fact that the problem was temperature-dependent was considered. This led to the 
discovery of the insertion in the origin of pCcdB.  Specifically, a 24 base pair insertion into 
the RNAII region of pCcdB's ColEI1 origin of replication proved to be the cause of the 
two-plasmid screen's disruption at 25°C (Fig. 7). RNAII initiates the replication of the 
leading strand on ColE1 origins, and it is plausible that an insertion here might disrupt this 
process in various ways, including the temperature of melting (Tm), secondary structure, 
or binding affinity to downstream enzymes55,58,59.  
However, the way it disrupted the screen hints at the possibility of using origins of 
replication in the ColE1 family with mutations to the RNAII regions as a different means 
of thermosensitive biocontainment. Plasmid copy number is inherently thermosensitive, 
which could suggest that alterations in that region amplify that property55,59,60.  
4.2 Creating and Screening LHE Mutagenic Libraries 
Admittedly, the libraries could have had higher complexities, but the complexities 
generated have proved sufficient thus far (Table 1). The randomized libraries have a largely 
balanced transition to transversion rate based on the clones sequenced, allowing an 
unbiased sampling of the available protein space (Table 2). While the clones sampled from 
the I-OnuI library have approximately twice the rate of transitions as transversions; this is 
likely due to random error when compared to the other two libraries and the Stratagene 
manual51. 
After screening 2600 clones in the initial screen, only 12 candidates were found, and they 
were all I-OnuI variants (Table 3). This might be related to the I-OnuI library being smaller, 
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therefore making the variants easier to find, and some luck that the correct variant existed 
in the smaller library. Of those 12, only 2 proved to have a survival percent of 0 at 37°C 
(Table 4). Between those two candidate I-OnuI variants, the best one was selected for 
subcloning and further validation (Table 4). I-OnuI P14Q behaved superbly in the in vivo 
assay after being subcloned into a new pEndo backbone, providing precisely the parameters 
that one would hope for when creating a thermosensitive biocontainment LHE. It displayed 
0% survival at 37°C and approximately 100% survival at 25°C (Fig. 8). 
4.3 Purification of I-OnuI WT, I-OnuI G177A, and I-OnuI 
P14Q. 
Purification of the wild-type I-OnuI enzyme proved to be difficult as it did not purify as 
well as the other two mutants during size exclusion chromatography (Fig 11). This may 
hint at the wild-type binding the DNA target more tightly than I-OnuI G177A and P14Q, 
although it is difficult to say without a controlled experiment with loading controls 
included. It is clear that the general problem in the first round of purifications was the lack 
of a high-salt wash to remove DNA, as I-OnuI is a DNA binding protein, and the addition 
of a high-salt wash removed a lot of contaminants (Fig 10., Fig. 11,  Fig 12)39,43,46.  
4.4 In Vitro Cleavage Assay with WT I-OnuI, P14Q, and 
G177A. 
The observation that the I-OnuI cleavage reaction appears to proceed through a nicked 
intermediate is in line with previous data on I-OnuI and other LHEs (Fig. 13B, Appendix 
E)38,61–67. A plausible explanation for I-OnuI P14Q's observed thermosensitivity in vivo 
would be the mutation in position 14, which destabilizes the N-terminal domain via the 
interfacial α-helix. Suppose the thermosensitive properties of I-OnuI P14Q were a result of 
changes in enzyme kinetics or folding at 37°C. In that case, these changes should be 
noticeable during an in vitro cleavage assay using the purified protein and its cognate 
target. In such a case, given the open circle intermediate transition to a final linear product, 
one would expect an accumulation of open circle product, and finally, less linear product. 
However, at both 25°C and 37°C, we fail to reject the null hypothesis that purified I-OnuI 
P14Q behaves differently than the wild-type enzyme (Fig. 13, Fig. 14). This would suggest 
that the thermosensitive property of I-OnuI is not a result of changes to the protein.  
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4.5 Two Codon Assay 
Following the in vitro cleavage assays, it became clear that there must be another cause for 
the thermosensitive properties I-OnuI P14Q displayed in vivo. After re-examining the 
coding sequence of P14Q, it became apparent that there was a silent mutation added to 
codon 2's 3rd position (GGA2GGC). This mutation was added via the primer DE1268 used 
to create the mutant libraries. Both the synonymous GGA2GGC mutation and the non-
synonymous P14Q mutation (CCG14CAG) were screened individually and compared to 
the mutant identified via the two-plasmid screen (GGA2GGC, CCG14CAG, Fig 15). 
Given that the in vitro cleavage assay showed that the protein itself was not responsible for 
the thermosensitivity of I-OnuI P14Q, it was unsurprising that both mutations were 
required for I-OnuI P14Q (GGA2GGC, CCG14CAG) to behave in a thermosensitive 
manner (Fig. 15, Table 5).  
4.6 Suggestions for further studies 
Future studies should attempt to elucidate the specific mechanism that gives I-OnuI P14Q 
its thermosensitive properties. To this end, the amount of transcript available to the cell at 
each temperature should be investigated using reverse transcriptase quantitative PCR. 
Additionally, an inquiry into the level of protein available using Western blot is required 
to compare them to the transcript levels between 25°C and 37°C. If the specific means by 
which thermosensitivity is conferred to I-OnuI P14Q becomes apparent after that, it should 
be possible to port this mechanism to I-LtrI and I-HjeMI. Next, it remains to be seen 
whether a thermosensitive LHE can be used in the context of other promoters or origins of 
replication. Furthermore, it is unclear whether thermosensitive LHEs can target the vector 
expressing them, and what the escape frequency would be under the context of self-
targeting.  
Finally, whether a self-targeting thermosensitive LHE could provide a useful means of 
containing a bacterial host to a living system remains to be seen as well. This final test 
could be done by gavaging mice with E. coli carrying a self-targeting (this would require 
moving the I-OnuI target sequence onto the same vector) version of pEndo-P14Q under 
control of a pBAD promoter grown up overnight in 2xYT and 0.2% glucose at 37°C. At 
various time points after gavaging, stool samples could be collected, serially diluted, and 
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quickly plated. Two types of plates would be needed: 100 µg/mL ampicillin and 0.2% 
arabinose, and 100 µg/mL ampicillin and 0.2% glucose. These plates would then be left 
at room temperature for 48 hours, and their survival rate could be calculated. This test 
would be similar to the one performed by Stirling et al. (2017)23. 
4.7 Conclusion 
Before this line of inquiry, most attempts at biocontainment have followed the same 
previously existing conventions, and instead of getting simpler and more modular, attempts 
at reducing escape rates were becoming increasingly complex. Most attempts at 
biocontainment share the same fundamental flaws of their predecessors. Additionally, 
these increases in complexity also increased the size of the biocontainment module. An 
ideal biocontainment method would be more straightforward and controlled by an inherent 
indicator of environmental escape, such as how a drop in temperature would indicate an 
escape from containment for many bacteria relevant to health and industry. A pertinent 
example application in the short-term for I-OnuI P14Q is a thermosensitive containment 
module on Hamilton et al.'s (2019) conjugative cas9 plasmid to eliminate bacterial 
infections in the gut25. Indeed, if this turns out to be a small temperature-sensitive module 
that is also reliable and resistant to inactivation, it would be an ideal candidate for many 
health-related and industrial applications of synthetic biology.  
A thermosensitive variant of a LAGALIDADG Homing Endonuclease (LHE) and its 
cognate target site would meet these requirements. This research has identified a strong 
candidate for temperature-based biocontainment to prevent escape from a 37°C incubator 
(or a living organism) to an environment at room temperatureIV. However, the exact 
mechanism responsible for I-OnuI P14Q's (GGA2GGC, CCG14CAG) thermosensitive 
property seen in an in vivo two-plasmid screen remains undetermined. The possible 
 
IV
 Important note: during the in vivo two-plasmid screen the LHE is targeting a bacteriostatic toxin-producing plasmid. 
So, 100% survival at 25°C in the two-plasmid screen would translate to 100% cleavage at 25°C when being used as a 
biocontainment mechanism. The same would be true for 0% survival in the two-plasmid screen at 37°C, where that would 
translate to 0% cleavage at 37°C when the LHE is employed as a biocontainment mechanism. 
55 
 
explanations include changes to the rate of transcription, changes in transcript stability, or 
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Appendix A: List of Primers  
Primer 
Name 
Sequence (5' to 3') Description 
DE 704 CCATAAGATTAGCGGATCCTACCTG Forward 
sequencing 




DE 705 CGGGAAGATGCGTGATCTGATCC Reverse 
sequencing 




DE 796 CACCGATATGGCCAGTGTG Sequencing 
primer for the 
end of CcdB, 
the I-OnuI 
target site, and 
the I-LtrI 
target site. 
DE 1268 TAAGAAGGAGATATACCCATGGGC Forward 
mutagenesis 




DE 1269 CCAATTCTGAGCGGCCGC Reverse 
mutagenesis 




DE 4282 CATTGGTAACTGTCAGACCA Sequencing 







DE 4668 GCATTTCCGCGGAGACAGATCGCTGAGATAGG Forward 
gibson 
assembly 
primer the new 
origin of 
replication 
DE 4669 TTGCGCGACGTCAACCTGCATTAATGAATCGG Reverse gibson 
assembly 
primer the new 
origin of 
replication 




















































Appendix D. I-OnuI G177A plates used to generate figure 12.  Note: the spots seen on 







Appendix E. I-OnuI P14Q and I-OnuI WT also display few differences across 
temperatures when looking at the percentage of open circle and closed products over 
time during an in vitro cleavage assay. Panel A, B, C, and D correspond to the charts of 
open circle at 37°C, coiled at 37°C, open circle at 25°C, and coiled at 25°C, respectively. 
In vitro cleavage assays were performed as described in methods using purified I-OnuI WT 
(N=4, black circles),  P14Q (N=4, blue circles), and G177A (N=4, orange circles) at 37°C 
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